Equitable Trust’s Neogen NEOG Stock Holding History

Equitable Trust’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,000	Closed	-$248K	–	287
2019 Q2	$248K	Hold	8,000	–	–	0.03%	255
2019 Q1	$230K	Hold	8,000	–	–	0.03%	258
2018 Q4	$228K	Buy	+8,000	New	+$250K	0.03%	245

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Equitable Trust's NEOG Position: Q3 2019 in Review

Equitable Trust sold out of Neogen (NEOG) in Q3 2019, closing a stake of 8,000 shares — an estimated $248K sold.

Equitable Trust first reported a position in NEOG in Q4 2018 and held it in 3 quarters. The position peaked at $248K in Q2 2019. 271 funds tracked by Wall St. Rank hold NEOG as of Q3 2019.

Equitable Trust reported no remaining Neogen position as of Q3 2019 after selling out during the quarter.
Equitable Trust sold 8,000 Neogen shares in Q3 2019, an estimated $248K.
Equitable Trust first reported a position in Neogen in Q4 2018 and held it in 3 quarters.
Equitable Trust's Neogen position peaked at $248K in Q2 2019.
271 funds tracked by Wall St. Rank held Neogen as of Q3 2019.

Based on Equitable Trust's 13F filing for Q3 2019, filed 19 Nov 2019.